KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Astrana Health (ASTH) Enterprise Value (2016 - 2025)

Astrana Health's Enterprise Value history spans 16 years, with the latest figure at $12.3 million for Q3 2025.

  • For Q3 2025, Enterprise Value rose 103.56% year-over-year to $12.3 million; the TTM value through Sep 2025 reached $13.5 million, up 103.92%, while the annual FY2024 figure was -$286.8 million, 42.88% up from the prior year.
  • Enterprise Value for Q3 2025 was $12.3 million at Astrana Health, up from -$573.3 million in the prior quarter.
  • Across five years, Enterprise Value topped out at $12.3 million in Q3 2025 and bottomed at -$573.3 million in Q2 2025.
  • The 5-year median for Enterprise Value is -$263.4 million (2023), against an average of -$306.0 million.
  • The largest annual shift saw Enterprise Value tumbled 845.92% in 2021 before it soared 103.56% in 2025.
  • A 5-year view of Enterprise Value shows it stood at -$205.0 million in 2021, then crashed by 36.3% to -$279.4 million in 2022, then plummeted by 79.77% to -$502.2 million in 2023, then skyrocketed by 42.88% to -$286.8 million in 2024, then surged by 104.29% to $12.3 million in 2025.
  • Per Business Quant, the three most recent readings for ASTH's Enterprise Value are $12.3 million (Q3 2025), -$573.3 million (Q2 2025), and -$491.2 million (Q1 2025).